Financhill
Buy
60

SMMT Quote, Financials, Valuation and Earnings

Last price:
$25.89
Seasonality move :
6.46%
Day range:
$23.88 - $26.85
52-week range:
$2.10 - $36.91
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
19,338.57x
P/B ratio:
54.81x
Volume:
4.4M
Avg. volume:
5.4M
1-year change:
478.82%
Market cap:
$18.9B
Revenue:
--
EPS (TTM):
-$0.35

Earnings Data

Next earnings date for SMMT
Aug 06
2025
Most recent earnings per share
-$0.09
Beat by $0.00
(May 1/2025)
Consensus Estimate
-$0.09
(May 1/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SMMT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/06/2025 Q2 -- -- -- -$0.09 --
05/01/2025 Q1 -- -- -$0.09 -$0.09 $0.00
02/24/2025 Q4 -- -- -$0.09 -$0.08 -$0.01
10/30/2024 Q3 -- -- -$0.08 -$0.07 -$0.01
08/06/2024 Q2 -- -- -$0.09 -$0.06 -$0.03
05/01/2024 Q1 -- -- -$0.06 -$0.06 -$0.00
02/20/2024 Q4 -- -- -$0.01 -- --
11/07/2023 Q3 -- -- -$0.03 -- --
08/09/2023 Q2 -- -- -$0.02 -- --
05/11/2023 Q1 -- -- -$1.43 -- --
03/09/2023 Q4 -- -- -$0.04 -- --
11/09/2022 Q3 -- -- -$0.14 -- --
08/11/2022 Q2 -- -- -$0.17 -- --
05/11/2022 Q1 -- -- -$0.22 -- --
03/17/2022 Q4 -- -- -$0.28 -- --
11/15/2021 Q3 -- -- -$0.20 -$0.29 $0.09
08/11/2021 Q2 -- -- -$0.27 -$0.18 -$0.09
05/17/2021 Q1 -- -- -$0.21 -$0.17 -$0.04
12/31/2020 Q4 -- -- -$0.18 -$0.21 $0.03
11/16/2020 Q3 -- -- -$0.26 -$0.24 -$0.02
06/30/2020 Q2 -- -- -- -$0.08 --
03/31/2020 Q1 -- -- -$0.01 -$0.02 $0.01
03/27/2020 Q1 -- -- -- -$0.40 --
03/27/2020 Q4 -- -- -- -$0.03 --
12/17/2019 Q4 -- -- -$0.05 -- --
10/11/2019 Q3 -- -- -$0.18 -$0.56 $0.38
06/12/2019 Q2 -- -- -$0.19 -$0.26 $0.06
03/27/2019 Q1 -- -- -$0.33 -- --
12/11/2018 Q4 -- -- -$0.63 -$0.15 -$0.47
09/14/2018 Q3 -- -- $2.43 -$0.39 $2.82
06/05/2018 Q2 -- -- -$0.53 -$0.14 -$0.40
04/11/2018 Q1 -- -- -$1.14 -$0.12 -$1.01
12/06/2017 Q4 -- -- -$0.20 -$0.13 -$0.07
08/31/2017 Q3 -- -- $1.09 $0.32 $0.77
06/14/2017 Q2 -- -- -$0.51 -- --
03/29/2017 Q1 -- -- -$0.50 -- --

Summit Therapeutics Earnings Questions

  • How Much did Summit Therapeutics Generate in Revenue Last Quarter?

    Summit Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Summit Therapeutics Beat Earnings Last Quarter?

    Summit Therapeutics announced earnings per share of -$0.09 which represents a beat of analyst forecast a -$0.09 per share.

  • Is Summit Therapeutics Profitable?

    Summit Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Summit Therapeutics EPS Next Year?

    Summit Therapeutics's earnings are forecast to decrease from -$0.31 per share to -$0.30 per share next year representing a decrease of -28.37%.

  • When is Summit Therapeutics's Earnings Date?

    Summit Therapeutics's next earnings date is August 6, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Forge Global Stock Go Down?
Why Did Forge Global Stock Go Down?

Shares of Forge Global (NYSE:FRGE), a platform that allows accredited…

Is GlobalFoundries On The Verge Of A Breakout?
Is GlobalFoundries On The Verge Of A Breakout?

GLOBALFOUNDRIES Inc. (NASDAQ:GFS) is as a semiconductor foundry whose chips…

Is Dick’s Sporting Goods Buying Foot Locker Smart?
Is Dick’s Sporting Goods Buying Foot Locker Smart?

Last week, Dick’s Sporting Goods (NYSE:DKS) announced that it would…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 38x

Buy
68
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 45x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
58
WIX alert for May 22

Wix.com [WIX] is up 1.88% over the past day.

Buy
81
DY alert for May 22

Dycom Industries [DY] is down 0% over the past day.

Sell
50
FICO alert for May 22

Fair Isaac [FICO] is down 0.46% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock